Clinical Chemistry Analyzers Market - By Product (Reagents [Buffer, Control], Analyzers [Benchtop, Floor-standing]), Test (Basic Metabolic, Liver, Renal, Lipid Profile), Modality (Centralized, Decentralized), End-use - Global Forecast 2024

Description

Global Clinical Chemistry Analyzers Market will grow at 4.1% CAGR during 2024-2032, driven by the rising prevalence of chronic diseases, increasing geriatric population, and growing investments in healthcare infrastructure.

A recent World Health Organization (WHO) report shows that non-communicable diseases (NCDs) now account for approximately 75% of global deaths annually. With conditions such as diabetes, cardiovascular diseases, and kidney disorders becoming more prevalent globally, there is an increasing need for accurate and timely diagnostic solutions. Clinical chemistry analyzers play a crucial role in diagnosing and monitoring these chronic conditions by measuring various biomarkers and parameters in patient samples. As the burden of chronic diseases continues to escalate, the demand for clinical chemistry analyzers could rise, driving market growth. Additionally, advancements in testing technologies and the development of novel assays for detecting and managing chronic diseases further contribute to the market expansion.

The Clinical Chemistry Analyzers Market is classified based on product, test, modality, end-use, and region.

The centralized analyzers segment will register significant growth during the forecast period due to the ability of centralized analyzers to handle a high volume of samples efficiently. These analyzers offer automated testing procedures, reduced turnaround time, and enhanced accuracy, thus improving overall laboratory productivity. With the growing demand for centralized testing facilities to streamline diagnostic processes and improve patient care, further segment growth is expected.

Liver panel segment will amass a decent Clinical Chemistry Analyzers Market Share by 2032 as the liver panel test is vital in assessing the overall health and function of the liver. Comprising a panel of biomarkers such as alanine transaminase (ALT), aspartate transaminase (AST), bilirubin, and alkaline phosphatase (ALP), among others, liver panel tests aid in the diagnosis and monitoring of various hepatic conditions, including hepatitis, cirrhosis, and liver cancer. With the rising prevalence of liver diseases globally, fueled by factors such as alcohol consumption, obesity, and viral infections, the demand for liver panel testing is witnessing a notable upsurge.

Asia Pacific Clinical Chemistry Analyzers industry is poised for substantial growth over 2024-2032, supported by a rapidly expanding healthcare infrastructure, increasing healthcare expenditure, and rising awareness regarding the importance of early disease diagnosis. Countries like China, India, and Japan are making significant investments in healthcare technology and infrastructure, driving the adoption of advanced diagnostic solutions, including clinical chemistry analyzers. Furthermore, the growing prevalence of chronic diseases is amplifying the demand for diagnostic services, thereby propelling market growth across diverse healthcare settings.

Product Code: 8435

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising geriatric population
  - 3.2.1.2 Increasing prevalence of chronic disorders and lifestyle diseases
  - 3.2.1.3 Growing adoption of point of care testing devices
  - 3.2.1.4 Increasing demand for laboratory automation
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of instruments
  - 3.2.2.2 Requirement for high capital investment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Reagents
- 5.2.1 Buffers
- 5.2.2 Calibrators
- 5.2.3 Controls
- 5.2.4 Standards
- 5.2.5 Other reagents
5.3 Analyzers
- 5.3.1 By technology
  - 5.3.1.1 Semi-automatic analyzers
  - 5.3.1.2 Fully automatic analyzers
  - 5.3.1.3 Point of care analyzers
- 5.3.2 By type
  - 5.3.2.1 Benchtop analyzers
  - 5.3.2.2 Floor-standing analyzers
5.4 Other products

Chapter 6 Market Estimates and Forecast, By Test Type, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Basic metabolic panel
6.3 Liver panel
6.4 Renal profile
6.5 Lipid profile
6.6 Thyroid function panel
6.7 Electrolyte panel
6.8 Speciality chemical tests

Chapter 7 Market Estimates and Forecast, By Modality, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Centralized
7.3 Decentralized

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals and clinics
8.3 Specialty clinics
8.4 Diagnostic laboratories
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

10.1 Abbott Laboratories
10.2 Danaher Corporation
10.3 EKF Diagnostics
10.4 F.Hoffmann-La Roche Ltd.
10.5 Hitachi Ltd.
10.6 HORIBA Ltd.
10.7 Ortho Clinical Diagnostics
10.8 QuidelOrtho Corporation
10.9 Siemens Healthineers AG
10.10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
10.11 Sysmex Corporation
10.12 Thermo Fisher Scientific Inc.

Clinical Chemistry Analyzers Market - By Product (Reagents [Buffer, Control], Analyzers [Benchtop, Floor-standing]), Test (Basic Metabolic, Liver, Renal, Lipid Profile), Modality (Centralized, Decentralized), End-use - Global Forecast 2024 - 2032